12 May 2021 --- Hofseth BioCare (HBC) is developing a delayed-release formulation of its OmeGo fish oil with Catalent. Catelent’s OptiGel DR capsule technology helps protect active ingredients that may be degraded by acid in the stomach. It also releases active ingredients directly in the intestines where they are absorbed, potentially enhancing bioavailability.
